Hypera (OTCMKTS:HYPMY) Stock Passes Above Fifty Day Moving Average of $7.58
Hypera (OTCMKTS:HYPMY) Stock Passes Above Fifty Day Moving Average of $7.58
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $7.58 and traded as high as $8.14. Hypera shares last traded at $8.12, with a volume of 2,876 shares traded.
Hypera Price Performance
The company has a market cap of $5.23 billion, a PE ratio of 19.33 and a beta of 0.82. The company has a fifty day moving average price of $7.58 and a 200 day moving average price of $7.25.
About Hypera
(Get Rating)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Featured Articles
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It's Cheap
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $7.58 and traded as high as $8.14. Hypera shares last traded at $8.12, with a volume of 2,876 shares traded.
Hypera S.A.(场外交易代码：HYPMY-GET Rating)在周四的交易中突破了50日移动均线。该股的50日移动均线为7.58美元，最高交易价格为8.14美元。Hypera股价最新报8.12美元，总成交量为2,876股。
Hypera Price Performance
Hypera性价比
The company has a market cap of $5.23 billion, a PE ratio of 19.33 and a beta of 0.82. The company has a fifty day moving average price of $7.58 and a 200 day moving average price of $7.25.
该公司市值为52.3亿美元，市盈率为19.33倍，贝塔系数为0.82。该公司的50日移动平均价为7.58美元，200日移动平均价为7.25美元。
About Hypera
关于Hypera
(Get Rating)
(获取评级)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA在巴西作为一家制药公司运营。它提供的处方药有Adacne、Addera、Apri、AmpliumG、请、赛莱他明、Celstone、Celstone Soluspana、Cizax、DECPRAX、衍生CMicro、Micro Drift、Dermol Fusid、Digedrat、双丙胺、双丙沙星、双丙松、双丙松、Emprol XR、Flow、Garasone、Halobx、Lipanon、Moon、Lydian、Macrodantin、MaxSulid、MilGamma、Mioflex-A、Nesina、Novotram、oximax、peridid、Perida混悬剂、Predsim、Pressaliv、Quadriderm、Rizi、Rizi、Softalm、acrotz、tinodin、umma和velunid品牌。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It's Cheap
- 免费获取StockNews.com关于Hypera的研究报告(HYPMY)
- MarketBeat：回顾中的一周8/1-8/5
- 如何利用高贝塔系数股票最大化你的投资利润
- 克罗诺斯集团(Cronos Group Inc.)营收上升，是时候收购了吗？
- 苹果为何可能在年底创下历史新高
- Beyond Meat不是没有希望，而且它很便宜
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Hypera Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Hypera和相关公司的最新新闻和分析师评级的每日简要摘要。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧